Revenue growth is entirely from Infrastructure (structural steel), while Life Sciences and Spectrum continue to shrink. The $1.8B adjusted backlog provides visibility into 2026-2027, but the company is burning cash at the holdco level ($2.5M cash at Non-Operating Corporate). Monitor the May 14 conference call for updates on potential asset sales (DBMG, HC2 Broadcasting) and progress on the FCC 5G Broadcast petition, which could unlock Spectrum value.
Price Chart
Executive Summary
INNOVATE Corp. reported Q1 2026 revenue of $364.8M (+33% YoY) and a net loss of $17.2M, narrowing from a $24.8M loss in Q1 2025. The Infrastructure segment drove the top-line growth with $357.9M in revenue (+35.1% YoY) and $23.0M in Adjusted EBITDA, while Life Sciences and Spectrum segments declined. Total Adjusted EBITDA surged 173.6% to $19.7M. The company highlighted a $1.8B adjusted backlog at DBMG, CE mark approval for MediBeacon's TGFR system in Europe, and 60+ new FCC license applications for Spectrum. However, the company remains deeply unprofitable with $679.6M in total debt and a $243.0M stockholders' deficit.
Key Financial Metrics
Key Facts
- Q1 2026 revenue of $364.8M, up 33.0% YoY from $274.2M
- Net loss attributable to common stockholders narrowed to $17.2M from $24.8M YoY
- Total Adjusted EBITDA of $19.7M, up 173.6% from $7.2M YoY
- Infrastructure segment revenue of $357.9M (+35.1% YoY), Adjusted EBITDA $23.0M
- Life Sciences revenue declined to $1.6M from $3.1M YoY; Spectrum revenue down to $5.3M from $6.2M
- DBMG adjusted backlog of $1.8B, flat vs Q4 2025; reported backlog $1.6B
- MediBeacon received CE mark for Transdermal GFR Monitor and Reusable Sensor in Europe
- R2 gross system sales outside North America increased 58.6% YoY
- Cash and cash equivalents of $134.6M, up from $112.1M at year-end 2025
- Total debt of $679.6M; stockholders' deficit of $243.0M
Financial Impact
Revenue grew $90.6M YoY; net loss improved by $7.6M; Adjusted EBITDA improved by $12.5M
Risk Factors
- Deeply negative equity of $243.0M with $679.6M in total debt
- Life Sciences revenue declining 48.4% YoY; Spectrum revenue declining 14.5%
- Holdco-level cash of only $2.5M, reliant on subsidiary distributions
- $489.4M in debt maturing in 2027, including $379.3M in 10.50% Senior Secured Notes
- Going concern risk noted in forward-looking statements
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 7 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001006837-26-000038 |
| Document: vate-20260514.htm | 0001006837-26-000038 |
| Document: q12026earningswebcast-vf.htm | 0001006837-26-000038 |
| Document: 0001006837-26-000038-index-headers.html | 0001006837-26-000038 |
| Document: 0001006837-26-000038-index.html | 0001006837-26-000038 |
| Document: 0001006837-26-000038.txt | 0001006837-26-000038 |
| 8-K Data (Synthetic) | 0001006837-26-000038 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 9, 2026 17d ago | 8-K | $6.99 | awaiting T+20 | — | $5.71 (−18.31%) |
Oct 5, 2026 22d ago | 8-K | $7.44 | awaiting T+20 | — | $5.71 (−23.25%) |
Oct 5, 2026 22d ago | Press Release | $7.44 | awaiting T+20 | — | $5.71 (−23.25%) |
Aug 24, 2026 9w ago | EFFECT | $7.49 $8.18 | ▼ −9.21% | ▼ −9.20% | $5.71 (+23.77%) |
Aug 19, 2026 9w ago | S-3/A | $7.81 $7.86 | ▼ −0.64% | ▼ −2.59% | $5.71 (+26.89%) |
Aug 18, 2026 10w ago | 8-K | $7.64 $7.14 | ▼ −6.54% | ▼ −5.55% | $5.71 (−25.26%) |
Aug 10, 2026 11w ago | S-3 / 424B5 | $7.13 $7.03 | ▲ +1.40% | ▲ +0.49% | $5.71 (+19.92%) |
Aug 10, 2026 11w ago | 8-K | $7.13 $7.03 | ▲ +1.40% | ▲ +0.49% | $5.71 (+19.92%) |
Aug 3, 2026 12w ago | 8-K | $7.30 $7.44 | ▼ −1.92% | ▼ −0.68% | $5.71 (+21.78%) |
Jun 1, 2026 21w ago | 8-K | $15.89 $18.67 | ▲ +17.50% | ▲ +18.79% | $5.71 (−64.07%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers